Increased levels of sEVs were observed in both aPL+ APS patients and aPL− patients with a history of thrombosis, suggesting that thrombosis rather than aPL plays a role in the release of platelet EVs. The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.